The conference, co-hosted by Mitsubishi UFJ Research and Consulting (MURC), Foundation for Innovative New Diagnostics (FIND), Global Health Innovative Technology Fund (GHIT), International AIDS Vaccine Initiative (IAVI), and Coalition for Epidemic Preparedness Innovation (CEPI), will bring together experts in preventive health technologies, such as surveillance, diagnostics, and vaccines, to discuss the latest innovations as well as ways to increase access through improvements in regulatory, registration, and delivery aspects of new medical products. The conference’s four sessions will focus on key topics in diagnostics, surveillance, vaccines, and access and delivery.
Date & venue
Date: 25 February 2019, Tokyo, Japan. Venue: Mitsubishi UFJ Research and Consulting (Tokyo Office), Seminar Room in 24th Floor
Opening | 9:00 am – 9:25 am
Welcome: Representative from Mitsubishi UFJ Research and Consulting
Opening remarks: Prof. David Heymann, Head and Senior Fellow, Center on Global Health Security, Chatham House
|(Session 1) The latest diagnostic technologies: point-of-care/rapid testing | 9:25 am–11:05 am|
|Panelists will discuss the latest trends and challenges in diagnostics and future directions, focusing on POCT/rapid tests.
Moderator: Ranald Sutherland, Consultant for Technology and Business Development, FIND
|(Session 2) The advent of new technologies and their contribution to global health surveillance | 11:05 am–12:45 pm|
|Panelists will discuss artificial intelligence, drones, and communications technologies, which have the potential to contribute to the management of infectious diseases.
Moderator: Michikazu Koshiba, Head, Center on Global Health Architecture, Mitsubishi UFJ Research & Consulting
Lunch break | 12:45 pm – 13:45 pm
|(Session 3) The latest innovations in vaccine research and development | 13:45 pm–15:25 pm|
|Panelists will discuss the latest scientific advancement, as well as new partnerships and models of collaboration.
Moderator: Anita Kawatra, Vice President, Communications, International AIDS Vaccine Initiative
|(Session 4) Ensuring access and delivery in low- and middle-income countries | 15:25 pm–17:05 pm|
|Panelists will discuss the factors that ensure access to new technologies in LMICs.
Moderator: Hayato Urabe, Director, Investment Strategy, Planning & Management, GHIT
Closing | 17:05 pm – 17:15 pm
Joint Reception | 17:45 – 18:45 pm